tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF

Compare Zelira Therapeutics (ZLDAF) vs. Competitors

Compare
16 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Zelira Therapeutics
$0.21
$5.12M
-2.09
25.00%
Invex Therapeutics Ltd.
AU$0.12
AU$9.39M
-19.84
78.57%
Regeneus Ltd.
AU$0.47
AU$13.78M
-2.29
51.28%
Avecho Biotechnology Limited
AU$0.01
AU$33.06M
-9.09
0.00%
AdAlta Ltd.
AU$0.01
AU$11.47M
-1.61
-50.00%
Neuroscientific Biopharmaceuticals Ltd.
AU$0.10
AU$46.56M
-11.11
250.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ZLDAF
Zelira Therapeutics
0.43
0.10
30.70%
AU:IXC
Invex Therapeutics Ltd.
0.13
0.05
71.23%
AU:CMB
Regeneus Ltd.
0.59
0.22
59.46%
AU:AVE
Avecho Biotechnology Limited
0.01
0.00
0.00%
AU:1AD
AdAlta Ltd.
0.01
-0.01
-50.00%
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.14
0.10
250.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts